EMBASSY OF THE REPUBLIC
OF THE PHILIPPINES


SEOUL REPUBLIC OF KOREA

news

PHILIPPINES SUPPORTS EFFORTS IN STRENGTHENING HEALTHCARE COOPERATION AND PARTNERSHIP IN THE INDO-PACIFIC REGION


21 December 2023, Seoul. The Philippines conveyed its support for efforts that strengthen healthcare cooperation and partnership in the Indo-Pacific Region at the 2023 Health Cooperation Forum in the Indo-Pacific Region on 13 December 2023 in Seoul. The forum was co-hosted by the Ministry of Foreign Affairs of the Republic of Korea, Department of Foreign Affairs and Trade of Australia and Department of State of the United States.

The forum aims to build a stronger vaccine cooperation network in the Indo-Pacific region. This year, under the theme "Building a Resilient Indo-Pacific Partnership on Vaccines and Healthcare", the forum's agenda has expanded to ASEAN-Korea cooperation on digital health, universal health coverage and workforce participation. Representatives from each ASEAN member state were invited as panelists in the special sessions.

Ms. Heidi Umadac, Supervising Health Program Officer of the Bureau of International Health Cooperation of the Department of Health (DOH-BIHC) was the Philippines' representative to the forum. She delivered the PH intervention with emphasis on the DOH's 8-point agenda to strengthening primary health care, utilizing digital health technology, health system resiliency, mental health and well-being, advancement and protection of health workers' rights and well-being and strengthening the health system and structure by mainstreaming health security, enhancing disease and public health surveillance, disease prevention and control, epidemic and pandemic response capabilities across levels of the healthcare system.

The Philippines also announced that the country's first vaccine manufacturing facility will soon rise as the Glovax Lifescience Corp. has started building its Php7.5 billion vaccine facility in Taysan, Batangas, that aims to produce 50 million doses annually. The facility is a partnership between PH local firm Glovax Biotech and ROK pharmaceutical company Eubiologics.

The Philippines looks forward to continued cooperation with the Republic of Korea on priority areas such as on the establishment of the Philippines' Center for Disease Control and Prevention digital health technology, supply chain management, pandemic response, capacity building for health workers on universal health care, and vaccine development. END

Other News


June 18, 2025
PISTANG PINOY SA KOREA 2025 DAEGU

Daegu, 10 June 2025 — The Filipino community in South Korea came together in vibrant celebration of Philippine culture and unity during PISTANG PINOY SA KOREA 2025, held in conjunction with the 127th Philippine Independence Day and 30th National Migrant Workers Day on 08 June 2025 at Yeungjin University, Daegu Metropolitan City.

Read More
June 12, 2025
PHILIPPINE EMBASSY IN SEOUL MARKS 127TH INDEPENDENCE DAY WITH SYMBOLIC LIGHTING OF BANPO BRIDGE

SEOUL, 12 JUNE 2025 – In celebration of the 127th Anniversary of the Proclamation of Philippine Independence, the Philippine Embassy in Seoul proudly hosted the Symbolic Lighting of Banpo Bridge in the vibrant colors of the Philippine flag on 12 June 2025, from 9:20 PM to 10:00 PM. This year’s Philippine Independence Day theme, “Kalayaan, Kinabukasan, Kasaysayan” (Freedom, Future, History), reflects the Philippines’ enduring journey toward a progressive future grounded in the sacrifices and triumphs of its past.

Read More
June 12, 2025
PHILIPPINE EMBASSY IN SEOUL COMMEMORATES 127TH INDEPENDENCE DAY WITH FLAG RAISING

SEOUL, 12 JUNE 2025 – Philippine Ambassador to the Republic of Korea Theresa Dizon-De Vega led the Philippine Embassy in Seoul in celebrating the 127th anniversary of the declaration of Philippine Independence through a flag raising ceremony in the Embassy rooftop on 12 June 2025. Philippine Government officials in Korea for various bilateral and multilateral engagements, and honor guards of the Armed Forces of the Philippines joined the Embassy personnel in the program.

Read More